| Literature DB >> 26062982 |
Abstract
The cellular component of ViaCyte's VC-01 combination product for type 1 diabetes, pancreatic endoderm cells (PEC-01) derived from CyT49 human embryonic stem cells, matures after transplantation and functions to regulate blood glucose in rodent models. The aims in manufacturing PEC-01 at scale are to generate a consistent and robust transplantable population that functions reliably and safely in vivo. ViaCyte has integrated multiple bioprocessing strategies to enable a tightly controlled PEC-01 manufacturing process for clinical entry. ©AlphaMed Press.Entities:
Keywords: Cell differentiation; Embryonic stem cells; Endoderm; Pancreas
Mesh:
Substances:
Year: 2015 PMID: 26062982 PMCID: PMC4511151 DOI: 10.5966/sctm.2015-0058
Source DB: PubMed Journal: Stem Cells Transl Med ISSN: 2157-6564 Impact factor: 6.940